Clinical Trial Update: Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease [Phase 1]

View source ↗

Summary

Open-label pharmacokinetic study evaluating Iron Isomaltoside 1000 (Monofer) administered as a 500 mg IV injection or a 1000 mg IV infusion in patients with inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Inflammatory Bowel Disease | Phase 1 | Status: COMPLETED